| Angiocentric T-cell lymphoma presenting as midface destructive lesion: case report and literature review. | |
| | |
MedLine Citation:
|
PMID: 12324793 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A case of angiocentric T-cell lymphoma presenting as a midface destructive lesion is reported. Angiocentric T-cell lymphoma typically manifests as an aggressive, progressively destructive, and necrotizing disorder, often with a fatal outcome. This case was characterized microscopically by the presence of an atypical lymphoid population that expressed a CD45+, CD3+ cytoplasmic, CD5+, and CD56- T-cell phenotype within a background of a polymorphous inflammatory infiltrate. Because of the rarity of the disorder, the differential diagnosis is discussed. Recent advances in clinical immunodiagnostics, the variations in therapeutic modalities, and the prognosis of the disease as reported in the recent literature are reviewed. |
| | |
Authors:
|
Wei Yung Yih; Jeffery C B Stewart; F James Kratochvil; Monica B Zieper |
Related Documents
:
|
17199743 - Malt1, bcl10 and foxp1 in salivary gland mucosa-associated lymphoid tissue lymphomas. 21965143 - Bilateral dysplasia epiphysealis hemimelica of the talus associated with a lower leg in... 15983693 - Pediatric myoepithelioma of the palate. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics Volume: 94 ISSN: 1079-2104 ISO Abbreviation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Publication Date: 2002 Sep |
Date Detail:
|
Created Date: 2002-09-26 Completed Date: 2002-12-17 Revised Date: 2006-04-24 |
Medline Journal Info:
|
Nlm Unique ID: 9508562 Medline TA: Oral Surg Oral Med Oral Pathol Oral Radiol Endod Country: United States |
Other Details:
|
Languages: eng Pagination: 353-60 Citation Subset: D; IM |
Affiliation:
|
Department of Pathology, Oregon Health & Science University, Portland, OR 97201, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Combined Chemotherapy Protocols
/
administration & dosage,
therapeutic use Cyclophosphamide / administration & dosage Doxorubicin / administration & dosage Humans Lymphoma, T-Cell, Peripheral / drug therapy, pathology*, radiotherapy Male Maxillary Sinus Neoplasms / drug therapy, pathology*, radiotherapy Middle Aged Nose Neoplasms / drug therapy, pathology*, radiotherapy, surgery Palatal Neoplasms / drug therapy, pathology*, radiotherapy Palatal Obturators Prednisone / administration & dosage Radiotherapy, Adjuvant Vincristine / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/CHOP protocol; 23214-92-8/Doxorubicin; 50-18-0/Cyclophosphamide; 53-03-2/Prednisone; 57-22-7/Vincristine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Juvenile xanthogranuloma of the oral cavity in children: a clinicopathologic study.
Next Document: Cytotoxicity of resin-based restorative materials on human pulp cell cultures.